These exemplary alternative pathways play a pivotal role in bolstering cellular survival and proliferation, effectively equipping cancer cells with the wherewithal to circumvent the therapeutic blockades imposed by PI3K inhibitors. The gene discussed is PIK3CB; the disease is cancer.